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Background: Monkey 20α-hydroxysteroid dehydrogenase (20α-HSD) is a catabolic enzyme responsible for
converting progesterone into biologically inactive 20α-hydroxyprogesterone, thereby playing a key role in the
estrous cycle or pregnancy and allowing ovulation and parturition to occur in most mammalian animals. Monkey
20α-HSD was highly abundant in ovarian and placental tissues during the pre-ovulation and pre-parturition phase and
was primarily localized in the syncytiotrophoblast of the placenta. In this study, we focused on the molecular
characterization of the monkey 20α-HSD promoter region by conducting reporter assays in Chinese hamster ovary
(CHO) K1 cells.
Results: A reporter assay using constructs of various lengths of the 5′-flanking region (−890-Luc, −513-Luc, −306-Luc,
−273-Luc, and −70-Luc) revealed that a region corresponding to the activator protein 1 (Ap-1) located between −281
and −274 bp was essential for the transcriptional activity. Absence of the Ap-1 site in −273-Luc dramatically decreased
the transcription levels to the control levels. When the reporter constructs were co-transfected with Ap-1 (Jun) and
specificity protein (Sp-1) genes, the transcription activities of the constructs increased with the exception of
−273 and −70, while that of the double construct was reduced compared to that of Ap-1 alone. Furthermore,
mutational analysis demonstrated that a putative Ap-1 site played an important role in the expression of the reporter
gene. These findings were confirmed by EMSA examining the interactions of the protein Ap-1 in a nuclear extract from
CHO-K1 cells and the expression levels of the Ap-1 transcription factor in pre-parturition placenta and CHO-K1 cells.
Although mut-1 and mut-2 of Ap-1 bound with nuclear extracts from CHO-K1 cells, the transcriptional activity of
mut-3 was almost completely suppressed.
Conclusions: Our results indicate that the Ap-1 site (−281→ −274) (5′-TGTCTCAT-3′) plays a crucial role in the activation
of the monkey 20α-HSD gene. Thus, we demonstrated that monkey 20α-HSD promoter activity is regulated by the
transcription factor Ap-1 in CHO-K1 cells.
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The steroid-metabolizing enzyme 20α-hydroxysteroid
dehydrogenase (20α-HSD; EC.1.1.1.149) catalyzes the
conversion of progesterone, a potent progestin, to the
metabolically inactive form 20α-dihydroprogesterone
(20α-OHP) [1]. This enzyme belongs to the aldo-keto
reductase (AKR) superfamily of nicotinamide adenine di-
nucleotide phosphate (NADPH)-dependent reductases that* Correspondence: ksmin@hknu.ac.kr
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article, unless otherwise stated.act on a wide range of substrates, including steroid hor-
mones and endogenous prostaglandins [2,3]. 20α-HSD
plays a crucial role in the modulation and regulation of
steroid hormones, such as androgen, estrogen, and proges-
tins [4].
The activity of 20α-HSD is known to be down-
regulated by prolactin (PRL) [5], allowing for the main-
tenance of progesterone secretion during the first half of
pregnancy. However, PGF2α stimulates the expression of
20α-HSD at the end of the pregnancy [6,7]. Administra-
tion of PGF2α to pregnant rats increases luteal 20α-HSD
activity [8]. PGF2α is also known to induce abortion inCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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deficient mice do not show the normal pre-partum drop
in progesterone [10,11]. Placental lactogen (PL) is an-
other suppressor of 20α-HSD gene expression. The
luteotrophic effects of both PRL and PL on the corpus
luteum (CL) are mediated via the PRL receptor [12].
Progesterone production in the rodent CL is regulated
by hormones, including PRL and PGF2α, which have
luteotropic and luteolytic functions, respectively [7].
There is additional evidence that PGF2α may act as
an inhibitor of the lactogenic suppression of 20α-HSD
expression by increasing the expression of a member
of the suppressor of cytokine signaling (SOCS) family,
SOCS-3, which has been demonstrated to interfere with
cytokine signaling through the Jak2/Stat5 pathway [13].
20α-HSD-deficient mice sustain high progesterone
levels and present a delay in parturition of several days,
demonstrating that 20α-HSD regulates parturition down-
stream of the PGF2α receptor in an essential and nonre-
dundant manner. 20α-HSD deficiency partially corrected
the abortion of pregnancies associated with Stab5b defi-
ciency [14]. The duration of the estrous cycle, pseudopreg-
nancy, and pregnancy was significantly prolonged in 20α-
HSD -/− mice [15]. Studies on the 5′-flanking region of
the mouse 20α-HSD gene demonstrated that the putative
Sp-1 site was critical for the expression of the reporter
gene on rat luteinized granulose cells [16]. In rats, the
regulatory elements of 20α-HSD (Nur77, Ap-1, CRE,
PRLRE, and PRE) are present within a 2.5-kb 5′-flanking
region of the gene. In addition, it was shown that the dele-
tion of this promoter at the −289 bp positions significantly
decreased the basal promoter activity [17]. PGF2α induces
the expression of the nuclear orphan receptor and tran-
scription factor Nur77 in the CL, which in turn leads
to the stimulation of 20α-HSD, triggering a decrease in
serum progesterone, which is essential for parturition
[18]. Thus, Nur77 plays an important role in ovarian
physiology by mediating the PGF2α-mediated induction of
20α-HSD in rats. In the human 20α-HSD gene, the tran-
scription factor-binding site for NF-Y/CEBP located be-
tween −128 and −88 is involved in controlling the basal
transcription of 20α-HSD in ovarian, lung, and liver car-
cinoma cells [19]. The transcription factor Sp-1 regulates
the overexpression of 20α-HSD in HT29 human colon
cells, which are resistant to methotrexate [20]. The activity
of the human 20α-HSD promoter luciferase was increased
by 1.7-fold upon treatment with PGF2α and oxytocin on
porcine ovarian follicle cells [21].
Among primates, 20α-HSD has been found in the pla-
centa of humans [22], rhesus monkeys [23], and baboons
[24]. In humans, the activity of 20α-HSD increased by 5-
fold in the placenta from mid to late gestation [25]. The
progesterone levels in baboon fetuses declined by almost
6-fold from mid to late gestation and this decrease wasaccompanied by a substantial increase in the concentra-
tion of 20α-OHP, a major metabolite of progesterone
[24]. Fetal progesterone concentrations decreased during
late pregnancy in the rhesus monkey [26]. In recent re-
ports, the expression of human 20α-HSD was detected
in the kidneys [27], adipose cells [28], skin [29], osteo-
blasts [30], and carcinoma cells from the lung [31],
endometrium [32,33], ovaries [34], guts [35] and skin
[36]. Over expression of 20α-HSD has been observed in
non-small-cell lung cancer [33] and in esophageal and
breast cancer [37,38].
We previously showed that 20α-HSD was highly de-
tected in ovarian and placental tissues during the pre-
ovulation and pre-parturition phases. It was mainly lo-
calized in the syncytiotrophoblast of the placenta and
isthmus cells of the oviduct in macaque monkeys [23].
However, the function and regulation of this enzyme in
primate reproductive physiology are not well known.
Human 20α-HSD gene is controlled by Sp-1 [19], but
there is no report on the regulation of the monkey 20α-
HSD promoter activity. Therefore, we analyzed that the
20α-HSD gene could be regulated by different transcrip-
tional factors depending on the species.
In the present study, to gain detailed information on
the transcriptional regulation factors, we investigated the
5′-flanking region of the monkey 20α-HSD gene pro-
moter. We demonstrated that the Ap-1 site of the mon-
key 20α-HSD gene is essential for its promoter activity,
is related to the interaction of the Ap-1 protein with the
nuclear extract from Chinese hamster ovary (CHO) K1
cells, and influences the expression of the Ap-1 tran-
scription factor in pre-parturition placenta and CHO-K1
cells.
Results
Analysis of putative transcription factor binding sites in
the monkey 20α-HSD gene promoter
The monkey 20α-HSD gene was used to construct the
5′-2005 bp basal promoter region. The transcription fac-
tor binding sites of the monkey 20α-HSD gene promoter
was analyzed using the TFsearch software. The promoter
region includes a TATA (−52→ −55) box and two puta-
tive CCAAT (−59→ −63; −105→ −109) boxes. More-
over, plural transcription factor binding sites were
identified, such as Ap-1, Oct-1, Sp-1, NUR77, NF-Y (nu-
clear factor-Y), CRE-BP (cAMP-response element), SRY,
and PRLRE (prolactin response element) (Figure 1A).
Various lengths of the 5′-flanking region were constructed
to identify the regulatory region crucial for the transcrip-
tion activity of the 20α-HSD gene. The deleted mutant
promoters were designed as −890-Luc (HSF-2), −510-Luc
(XFD), −273-Luc (Ap-1), and −70-Luc (Sp-1), and three
mutants were cloned into the PGL-3 Basic vector
(Figure 1B).
Figure 1 Putative transcription factor binding sites in the 5′-flanking region of the monkey 20α-HSD gene. A) Sequences approximately
2.5 kb upstream from the translation start codon of the monkey 20α-HSD gene. Putative transcription factor binding sites were identified using
the TFsearch software. The region includes GR, Ap-1, Oct-1, Sp-1, CRE-BP1 and others. The TATA (−52→ −55) box and two putative CCAAT
(−59→ −63; −105→ −109) box sites are indicated in bold. B) The translation start codon is indicated as +1. The region between −350 and −53
has a cluster of transcription factor binding sites that are believed to be important for the basal expression of the monkey 20α-HSD gene.
Figure 2 Promoter activity of the serially deleted 5′-flanking region
of the monkey 20α-HSD gene. The −890-Luc, −513-luc, −273-Luc,
and −70-Luc fragments were generated by PCR amplification and
inserted into the pGL3-basic vector. CHO-K1 cells were transfected with
the constructs. The results are presented as a percentage of the relative
luciferase activity compared with the wild-type. Graphs show the
mean ± SEM of three independent experiments.
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The pGL3-basic vectors were constructed with promoter
deletion mutants of different lengths and their activities
were assayed in hamster ovarian cells in comparison
with the 2005-bp promoter + pGL3 vector (positive con-
trol) and non-transfected cells (negative control). As
shown in Figure 2, the series of deletion constructs had
similar promoter activities. However, when the two con-
structs −273-Luc and −70-Luc were transfected, the lucif-
erase activity dramatically decreased. In particular, −70-
Luc activity was identical to that of the basic pGL3 expres-
sion plasmid. Thus, we postulated that the Ap-1 site
(−281 to −274) plays an important role in the activation of
the promoter of the monkey 20α-HSD gene. The −306-
Luc and −513-Luc constructs containing the Ap-1 site
were generated, and their luciferase activities were almost
the same (Figure 3). The activity of −273-Luc highly de-
creased compared to that of −513-Luc and −306-Luc.
Next, to investigate whether these factors affected the
transcription of monkey 20α-HSD gene, we transiently
Figure 3 Promoter activity of the deletion regions with/without the Ap-1 site. The deletion constructs with/without the Ap-1 site were
amplified and then inserted into the pGL3-basic vector. The promoter activities of the constructs were analyzed by transfection into the CHO-K1
cells. The −306-Luc fragment has an Ap-1 site (5′-TGTCTCAT-3′) from −281 to −274. The −273-Luc fragment does not have an Ap-1 site.
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bination with the Ap-1 or Sp-1 expression plasmids in-
dividually and together. The luciferase activity of the
three constructs, with the exception of −273-Luc and
−70-Luc, co-transfected with the Ap-1 and Sp-1 ex-
pression plasmids was high compared to that when
only one plasmid was transfected. However, the activ-
ity of the −273-Luc and −70-Luc constructs, which
did not contain the Ap-1 binding site, did not in-
crease when co-transfected with the Ap-1 and Sp-1Figure 4 Transcription activity of the serially deleted promoter region
lengths were transfected or co-transfected with the pCMV-Sp1 or pSG5-Ap
the luciferase reporter constructs and factor expression vectors were used at
for triplicate wells) is presented as the percentage of the activity resultinexpression plasmids (Figure 4). Therefore, the pro-
moter activity of the monkey 20α-HSD gene may
be related to the Ap-1 transcription factor located be-
tween −281 and −274. Moreover, the Sp-1 site
between −79 and -70 bp is also dispensable to promoter
activity (Figures 3 and 4). This region specifically contains
IRF-1, 2, Brn-2, CP-2, Sox-5, and GR (Figure 1A). It is also
interesting to note that the region between −273 and −70
contains critical regulation sites (e.g., NF-Y, NUR77 and
Sp-1; Figure 1B).s. The pGL3-basic vector constructs containing fragments of various
1 expression vectors into CHO cells. For the co-transfection experiments,
1:4 concentration ratio. The relative luciferase activity (mean ± SEM
g from the promoter transfection alone in each group.
Nanjidsuren and Min BMC Biotechnology 2014, 14:71 Page 5 of 11
http://www.biomedcentral.com/1472-6750/14/71Analyses of the putative Ap-1 binding site by site-
directed mutagenesis
Based on the above results, to investigate whether prevent-
ing the binding of Ap-1 resulted in decreased the transcrip-
tion of the 20α-HSD gene, we constructed the −288-Luc
deletion mutant including the Ap-1 binding site (5′-
TGTCTCAT-3′). Additionally, we also constructed mu-
tants within the Ap-1 binding site (Table 1), transfected
them into CHO cells alone or with the Ap-1 transcription
factor, and compared the results with the positive control
(−288-Luc). As shown in Figure 5, the luciferase activities
of mutant-1 (mut-1) and mutant-2 (mut-2), in which half
of the Ap-1 site nucleotides were mutated, were not signifi-
cantly affected. However, the transcription activity of
mutant-3 (mut-3), which had all eight nucleotides of the
Ap-1 region mutated, significantly decreased. Moreover,
the activity of −288-Luc co-transfected with the Ap-1 ex-
pression plasmid increased more than that of mut-1. The
activity of mut-2 and mut-3 co-transfected with the Ap-1
expression plasmid did not change. However, as shown in
Figure 5, the activity of mut-3 co-transfected with Ap-1 de-
creased. These results demonstrate that Ap-1 transcription
factor (5′-TGTCTCAT-3′) has a specific binding site for
the monkey 20α-HSD gene located in the −281→ −274
region.
Ap-1 expression in CHO cells and monkey placenta and
analysis by EMSA
The Ap-1 expression level in the placenta from the pre-
parturition period and the CHO-K1 cell line was deter-
mined by RT-PCR and Western blot (Figure 6A,B).
Strong expression of Ap-1 mRNA was detected in both
CHO-K1 cells and placenta at pre-parturition. We also
found that the Ap-1 protein was coordinately expressed
as a nuclear and cytoplasmic protein in CHO cells.
However, the expression of the Ap-1 protein in theTable 1 Oligonucleotides used for the construction of the
reporter vectors and EMSA
Constructs Nucleotide sequence (5′ 3′)
pGL3 (−2005-Luc) GAG ACG GGG TTT CTC CAT
pGL3 (−890-Luc) TCT TAC AAG GCT AAT AAG AA
pGL3 (−513-Luc) AGT AAA CTT TAA TTT TTA AT
pGL3 (−273-Luc) AAA TAG AGA CTT GGA ATA GC
pGL3 (−306-Luc) ACA AAT CTC TTT GAA TAA TT
pGL3 (−288-Luc) TTT ATG TCT CAT AAA TAG AG
pGL3 (−70-Luc) CTG CTC ATT GGT CTT ATA GC
pGL3 Reverse CAT TTC TGT CAC TGG CCT
EMSA probe WT GAA TAA TTT ATG TCT CAT AAA TAG AGA CTT
EMSA probe mt-1 GAA TAA TTT Aca caT CAT A AA TAG AGA CTT
EMSA probe mt-2 GAA TAA TTT ATG TCg agg AAA TAG AGA CTT
EMSA probe mt-3 GAA TAA TTT Aca cag agg AAA TAG AGA CTTmonkey placenta was weak. Consensus fragments of the
oligonucleotide probes for the Ap-1 mutants were also
synthesized. For the EMSA, a nuclear protein extract
was prepared from CHO cell and used with 3′-end
biotin-labeled 30 bp (from -292 nt to -262 nt) oligo-
nucleotide probes. Preliminary EMSA analysis showed
the presence of Ap-1 protein-DNA complexes. The mu-
tants used for the EMSA (mut-1, −2, and −3) were simi-
lar to those employed in the luciferase assay. The
binding of mut-1 and mut-2, which had half of the nu-
cleotides mutated, did not compete with the DNA bind-
ing as well as the WT construct. However, mut-3, which
had all the nucleotides mutated, did compete with the
DNA binding (Figure 6C). Thus, partial mutations of the
Ap-1 binding site did not affect the basal activity. There-
fore, in the present study, we have functionally charac-
terized the monkey 20α-HSD gene basal proximal
promoter and provided evidence of the role of the Ap-1
in CHO cells.
Discussion
In the present study, we characterized for the first time
the transcription activity and regulation of the 5′-
flanking region of the monkey 20α-HSD gene located
in the −281→ −274 region relative to the translational
start. This study demonstrated that the Ap-1 site plays
a crucial role in the transcription of the monkey 20α-
HSD gene in CHO cells. Moreover, we clearly demon-
strated that Ap-1 is indispensable for the regulation of
the expression of the 20α-HSD gene. The Ap-1 tran-
scription factor is crucially involved in a multitude of
cellular processes, including development and differen-
tiation, cell proliferation, apoptosis, oncogenic transform-
ation, and the response to genotoxic agents [39,40]. The
activity of this transcription factor is modulated by growth
factors, cytokines, and tumor promoters, such as the phor-
bol ester 12-O-tetradecanoylphorbol 13-acetate (TPA)
[40]. Jun homodimers have less DNA binding activity than
do Jun/Fos heterodimers [41]. Moreover, the function of
the Ap-1 dimer is cell type-specific and cell cycle-
dependent [42,43]. Recently, we reported that the monkey
20α-HSD mRNA was highly expressed in pre-parturition
placenta and pre-ovulation ovary, and it was localized in
the syncytiotrophoblast of the placenta. The promoter re-
gion of the 5′-flanking region was cloned and the EGFP
expression signal under the monkey 20α-HSD 2005-bp
promoter functioned normally in the CHO cell line [23].
In this study, we analyzed the expression of the Ap-1
factor in the pre-parturition placenta of monkey and in
hamster ovarian cells. In rat ovarian cells, the Ap-1 fac-
tor exhibited a specific expression pattern and response
to hormones. Rapid induction of JunB, c-Fos, and Fra-2
by FSH revealed a pattern of other immediate-early
genes in granulose cells [44]. Ap-1 proteins are specific
Figure 5 Effect of nucleotide conversion mutation in the putative Ap-1 site on the promoter region of the monkey 20α-HSD gene on
the transcription activity. The Ap-1 transcription factor binding sites are indicated in bold and the conversion-mutated nucleotides are indicated
by a smaller character. The luciferase reporter constructs and Ap-1 transcription factor expression vectors were co-transfected at 1:4 concentration
ratio. The relative luciferase activity (mean ± SEM for triplicate wells) is presented as the percentage of the activity of the 288 bp-pGL3 construct.
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the trophoblast. Most of the Ap-1 family factors are also
expressed in the intermediate trophoblast of the placenta
during the first trimester and later during pregnancy,
with the expression being stronger for JunD and Fra2,
followed by c-Jun, c-Fos, and FosB. Furthermore, JunD wasFigure 6 Expression of the Ap-1 (Jun) factor and EMSA analysis with
CHO cells and monkey placenta by RT-PCR. B) Ap-1 protein was analyzed i
by western blot. C) EMSA was performed for the wild-type (−288-Luc) and
extract (3 μg) from CHO cells using 20 fmol of biotin-labeled double-stran
a Zeta probe membrane. Detection of biotin-labeled DNA was performed usiexpressed in the syncytiotrophoblast [45]. Ap-1 is involved
in placenta-specific expression of the mouse and human
lactogen I (PL) gene [46,47], human chorionic somato-
mammotropin A and B [48], human gonadotropin-
releasing hormone receptor gene [49], and the collagen
digesting enzyme metalloproteinase (MMP)-1 gene thatnuclear extract from CHO-K1 cells. A) Ap-1 mRNA was detected in
n the total, nuclear, and cytoplasmic proteins extracted from CHO cells
nucleotide-converted mutants (mut-1, mut-2, mut-3) with nuclear
ded oligonucleotide probe. The protein-DNA complex was transferred to
ng the LightShift chemiluminescent EMSA kit and exposed to X-ray film.
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[50]. In humans, the expression of Ap-1 and NFkB in-
creased in the cervical stroma at the time of parturition. In
particular, c-Jun significantly increased in the end of preg-
nancy and c-Fos immediately increased after parturition,
suggesting MAPK activation during cervical ripening be-
fore labor [51,52].
In the present study, a reporter assay using constructs
of various lengths of the 5′-flanking region revealed that
the Ap-1 region between −281 and −274 bp was essen-
tial for transcriptional activity. According to the gel
shifting assay, the mutant mut-3, which had all the nu-
cleotides mutated, did not have DNA binding activity
compared to the wild type, mut-1, or mut-2 Ap-1 factor
binding sites. Recent studies demonstrated that human
20α-HSD was regulated by the nuclear factor-Y (NF-Y)
in human ovarian, liver, and lung carcinoma cells [19].
However, gel shift assays revealed an increase in Sp1 and
Sp2 binding compared to sensitive cells in methotrexate-
resistant HT29 human colon cancer cells, without differ-
ences in the Sp1 protein levels [20]. A reporter assay of
the 5′-flanking region of the mouse 20α-HSD gene re-
vealed that the region between −83 and 60 bp upstream
of the transcription start site was essential for the tran-
scriptional activity in rat luteinizing granulose cells [16].
A putative Sp1 site in this region was critical for the
expression of the reporter gene. Finally, the promoter
activity was enhanced by the co-transfection of Sp1 ex-
pression vector. Thus, the Sp-1 site between −79 and
-70 bp needs to be mutated and the activity of the mon-
key 20α-HSD mutant promoter tested. However, our re-
sults indicate that the monkey 20α-HSD gene was
regulated by Ap-1. Thus, we suggest that the 20α-HSD
gene could be regulated by different transcriptional fac-
tors depending on the species.
PRL signals through the Jak2/Stat5 pathway downreg-
ulate rat 20α-HSD expression in the decidua. Thus, de-
cidual PRL plays an important role in pregnancy by
repressing the expression of interleukin-6 (IL-6) and
20α-HSD in the decidua [53]. The different types of hu-
man 20α-HSD inhibitors were reported in an update on
the design of potent and active inhibitors based on the
crystal structure of the enzyme-inhibitor complex [52].
PGF2α induces the expression in the CL of the nuclear
orphan receptor and transcription factor NUR77, which
in turn leads to the transcriptional stimulation of rat
20α-HSD, triggering the decrease in serum progesterone,
which is essential for parturition [7]. The activation of
Jun D through a calmodulin-dependent activation of
extracellular signal regulated kinases (ERk) 1/2 mediates
NUR77 induction by PGF2α [18]. When forskolin was
used to treat luteal cells transfected with the 2.5-kb rat
20α-HSD promoter reporter gene, it caused a dose-
dependent inhibition of luciferase activity within 24 h[17]. We also collected data on the acceleration and
downregulation of the monkey 20α-HSD gene promoter
by PGF2α and forskolin (unpublished data). In humans,
during cervical ripening and dilation, the presence of the
20α-HSD enzyme results in progesterone inactivation,
attenuation of progesterone action, and cervical ripening
[54]. In mouse, knockout experiments have revealed
non-redundant functions of most of the Ap-1 family
members. With regard to the utero-placental system,
these experiments pointed to a specific role for JunB
and Fra-1. Inactivation of each of the corresponding
genes led to severe growth retardation and early fetal
death due to impaired vascularization of the decidua
[55,56]. Although the NUR77, NF-Y, and Sp1 sites were
contained inside the Ap-1 site of the monkey 20α-HSD
promoter, we did not perform analyses to detect the
complete suppression of the transcriptional activity of
the deletion mutants of the Ap-1 site. However, the 20α-
HSD gene was regulated by these factors in humans,
mice, and rats. Thus, further studies aiming to clarify
the regulation of the 20α-HSD gene promoter are
needed.
Conclusions
Taken together, these findings indicate that the Ap-1
transcription factor might play a dynamic role in mon-
key and mammalian reproductive physiology. Our previ-
ous study determined that the 20α-HSD enzyme is
important in the monkey estrous cycle and parturition.
In this study, we suggest that 20α-HSD gene expression
in the ovary and placenta is regulated by Ap-1 in the
monkey reproductive system during pregnancy and pre-
parturition. Furthermore, we suggest that the 20α-HSD
activity may be important for protecting the fetus from
high progesterone levels during parturition because Ap-
1 regulates 20α-HSD gene expression in the placenta
and ovaries.
Methods
Animal tissues and cell lines
Tissue samples were obtained from the Korea National
Primate Research Center (Ohchang, Korea). Placental
tissues from an 8-year-old female rhesus monkey of
Chinese origins were collected by cesarean section in the
pre-parturition period as described previously [23]. The
tissues were immediately frozen in liquid nitrogen and
stored at −80°C until use. CHO-K1 cells were obtained
from the Japanese Cancer Research Resources Bank
(Tokyo, Japan). CHO-K1 cells were cultured in Ham's
F12 medium (Gibco, MD) containing penicillin (50 U/
mL), streptomycin (50 mg/mL), glutamine (2 mM), and
10% fetal bovine serum (FBS). The cells were incubated
at 37°C under 5% CO2 atmosphere. All animal housing
and experiments were performed in accordance with the
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ogy (KRIBB) Institutional Animal Care and Use Com-
mittee Guidance (Accepted No. KRIBB-AFC-09017).
Construction of luciferase reporter vectors and Ap-1 site
mutants
The monkey 20α-HSD gene promoter (2005-bp) was
cloned using the long amplification polymerase chain re-
action (LA-PCR) cloning method as described previously
[23] and the potential transcription factor binding sites
within the 20α-HSD gene promoter were screened using
the TFsearch program (Kyoto University, Japan). To iden-
tify the critical trans-activation region of the 20α-HSD
promoter, a series of deletion fragments [−890-Luc, −513-
Luc, −306-Luc, −273-Luc, and −70-Luc relative to the
translational start codon (+1)] were generated by PCR
amplification using the template cloning vector containing
the 2005-bp 20α-HSD promoter region and the primers
shown in Table 1. The primers contained the KpnI site at
the 5′-end and the XhoI site at the 3′-end of each frag-
ment. The PCR fragments were subcloned into the
pCR2.1 vector and verified by sequencing to rule out the
possibility of any PCR error. The correct plasmids were
digested with KpnI and XhoI, and then inserted into the
same digested sites of the pGL3-Basic luciferase reporter
vector (Promega, Madison, WI). Nucleotide inversion mu-
tants (mut-1, mut-2, and mut-3) of the putative Ap-1 site
were constructed according to the two-step overlapping
PCR method [57] using the primers shown in Table 1.
PCR was performed with Ex taq polymerase (TaKaRa,
Osaka, Japan), and the mutant fragments were subcloned
into the pCR 2.1. Finally, the mutants were sequenced and
inserted into the pGL3 luciferase vector as described
above.
Transient transfection and luciferase assay
For the luciferase assay, CHO cells were plated at dens-
ity of 0.5 × 105 cells per well in 500 μL of growth
medium without antibiotics 24 h before transfection. On
the next day, the cells were washed twice, and 150 μL of
Opti-MEM (Invitrogen, Carlsbad, CA) was added to
each well. Each vector (0.8 μg) was mixed with 1 μL of
LipofectamineTM2000 (Invitrogen, Carlsbad, CA) reagent
in 100 μL of Opti-MEM and incubated at room
temperature for 20 min. Afterwards, the Lipofectamine-
DNA complex was added to each well. After 4 h, 250 μL
of CHO growth medium containing 20% (v/v) FBS was
added. After incubation for 24 h, the cells were washed
twice, 500 μL of CHO-S-SFM-II was added to each well,
and the cells were incubated for additional 24 h. Finally,
the luciferase activity was measured using a Dual-GloTM
luciferase assay system kit and a 20/20 Glomax Lumin-
ometer (Promega, Madison, WI) according to the manu-
facturer’s instructions. Ap-1 (c-Jun: AF069514) and Sp-1expression vectors were provided by Dr. K. Imakawa (The
University of Tokyo) and Dr. YC. Chang (Catholic Univer-
sity of Daegu School of Medicine). Rabbit polyclonal anti-
body against mouse Jun was bought from Santa Cruz
Biotechnology (Santa Cruz, CA, USA).
In co-transfection experiments, pCMV-Sp1 or pSG5-
Ap1 expression vector was mixed with the luciferase
vectors at 1:4 concentration ratio. All experiments were
repeated at least three times, and representative results
were shown. The results of the luciferase assays are
expressed as the mean ± standard error of the mean
(SEM).
cDNA synthesis and polymerase chain reaction
Total RNA was extracted using TRIzol reagent (Invitro-
gen, Carlsbad, CA). Monkey placenta and CHO cells
(100 mg) were added to 1 mL of TRIzol reagent and ho-
mogenized. Then, 0.2 mL of chloroform was added per
1 mL of TRIzol reagent, and the samples were vigorously
vortexed for 15 s. Samples were centrifuged at 12,000 × g
for 15 min at 4°C. After centrifugation, the upper aque-
ous phase was transferred into a fresh tube and 0.5 mL
of isopropyl alcohol was added. The RNA pellet was
washed twice with 75% DEPC water. Finally, the concen-
tration and purity of the RNA was determined by spec-
trophotometry at 260 nm and 280 nm. cDNA was
synthesized as described previously [23]. Two microliters
of cDNA was used in each PCR. The Ap-1 (Jun) region
was amplified by using forward (5′-ATG ACT GCA
AAG ATG GAA ACG-3′) and reverse (5′-TCA AAA
TGT TTG CAA CTG CTG CTG-3′) primers. The PCR
was performed under the following conditions: 94°C for
1 min; 30 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C
for 50 s; final extension at 72°C for 10 min. Primers for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
were used for the normalization of the expression of
Ap-1. The sequences of the forward and reverse primers
were 5′-ACC ACA GTC CAT GCC ATC AC-3′ and 5′-
TCC ACC ACC CTG TTG CTG TA-3′, respectively. The
expected length of the PCR fragment was 452 bp. The
PCR conditions were 26 cycles of 98°C for 10 s, 55°C for
20 s, and 72°C for 20 s. Gel electrophoresis was used to
analyze 5 μL of the PCR products.
Preparation of nuclear extracts and Western blot analysis
Nuclear extracts were prepared according to the proto-
col of the NE-PER Nuclear and Cytoplasmic Extraction
Reagents Kit (Thermo Scientific, Marietta, OH). For nu-
clear extraction, the CHO cells were seeded at a density
of 1.5 × 106 cells in 100-mm culture dishes. After 100%
of the dish area was covered by cells, the cells were tryp-
sinized and washed with ice-cold 1× PBS and centri-
fuged at 500 × g for 5 min. Then, the cell pellet was
dried. The cells were re-suspended in 200 μL ice-cold
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cocktail, vortexed for 15 s, and incubated on ice for
10 min. Then, 11 μL of ice-cold CERII buffer was added
to the tube, the samples were vortexed for 5 s, and incu-
bated on ice for 1 min. The tube was centrifuged for
5 min at 4°C, and the supernatant (cytoplasmic extract)
was transferred to a pre-chilled tube. Finally, the insol-
uble fraction containing the nuclei was suspended in
100 μL of ice-cold NER buffer containing a protease in-
hibitor cocktail, vortexed for 15 s, and placed on ice for
40 min. The tube was centrifuged at 4°C, 16,000 × g for
10 min, the supernatant (nuclear extract) was recovered
to a pre-chilled tube, and the extracts were stored at −
80°C until use. The protein concentration was deter-
mined by the Bradford’s colorimetric assay (Bio-Rad,
Hercules, CA) using bovine serum albumin (BSA) as the
standard [58].
Monkey placenta and CHO cell total proteins were ex-
tracted using PRO-PREP (Intron Biotech, Seoul) protein
extraction solution. Approximately 15 mg of tissues were
minced, and the confluent CHO cells in 100-mm dishes
were washed in 1× PBS. The samples were then homog-
enized in 600 μL of PRO-PREP solution. The cell lysis
reaction was induced by incubating the cells for 30 min
on ice. Then, the samples were centrifuged at 13,000 rpm
at 4°C for 5 min and the supernatant was transferred to a
fresh tube. Finally, the protein concentration was mea-
sured using the Bradford's method [40]. The protein sam-
ples (10 μg) were subjected to SDS-PAGE and transferred
to a PVDF membrane using a semidry electro-blotter ap-
paratus for 3 h. Then, the membrane was washed with 1×
PBST solution and blocked with 5× skim-milk blocking
solution for 1 h. The membrane was probed with a c-Jun
rabbit monoclonal antibody (Cell Signaling Technology,
Danvers, MA) washed to remove the unbound antibody,
and incubated with the secondary antibody goat anti-
rabbit horseradish peroxidase (HRP; Abcam, Cambridge,
MA), for 30 min. Finally, the membrane was incubated for
5 min with 3 mL of Lumi-Light substrate solution and ex-
posed on X-ray film for 30 s–5 min.
Electrophoretic mobility shifting assay (EMSA)
Wild-type and mutant probes were amplified as double-
stranded oligonucleotides (Table 1) from the −291 to
−262 region of the 20α-HSD promoter. Mutation of the
binding consensus site was checked by sequencing, and
the fragment was purified by the silica-based Gene Clean
II kit (MP Biomedicals, Cleveland, OH) and ammonium
acetate DNA precipitation method. All the probes were
labeled with biotin using the Biotin 3′-End DNA Label-
ing kit (Thermo Scientific, Marietta, OH) according to
the manufacturer’s instructions. For EMSA, 3 μg of the
nuclear extract was utilized for the binding reactions with
20 fmol of biotin-labeled double stranded oligonucleotideprobe. The EMSA binding reactions were performed at
room temperature for 30 min. in a reaction buffer con-
taining 2.5% glycerol, 5 mM MgCl2, 0.05% NP-40, and
50 ng of poly-(dI-dC) for each reaction. The reaction mix-
tures were loaded on a 6% non-denaturation polyacryl-
amide gel in pre-chilled 0.5% Tris-EDTA buffer and run at
100 V. The protein-DNA complexes were then transferred
to a Zeta probe membrane using the Trans-Blot semi-dry
method (Bio Rad, Hercules, CA) and cross-linked using
the BLX-254 UV cross-linker. Detection of biotin-labeled
DNA was performed using the LightShift chemilumines-
cent EMSA kit (Thermo Scientific, Marietta, OH), and the
membrane was exposed to X-ray film.
Data and statistical analysis
One-way ANOVA Newman–Keuls Multiple Comparison
tests were used to compare the results between samples
using GraphPad Prism 5 (GraphPad Software, San
Diego, CA). Asterisks indicate significant differences
from the control group. (*P < 0.05, **P < 0.01, ***P <
0.001).
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